Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOCLEAN A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   9.5% 9.5% 9.5% 9.5% 9.5% 9.5% 9.5% 9.5%   Bankruptcy risk   0.8% 0.6% 1.4% 0.8% 0.9% 1.6% 6.1% 5.9%   Credit score (0-100)   93 97 78 92 88 74 39 39   Credit rating   AA AA A AA A A BBB BBB   Credit limit (kDKK)   700.5 819.5 34.4 1,445.7 557.7 24.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   10,528 11,761 5,446 11,255 13,766 17,878 0.0 0.0   EBITDA   2,464 2,544 456 5,878 6,059 4,290 0.0 0.0   EBIT   2,040 1,818 -692 4,584 4,836 2,496 0.0 0.0   Pre-tax profit (PTP)   1,623.4 1,337.9 -1,248.1 4,314.5 4,132.9 1,683.4 0.0 0.0   Net earnings   1,124.8 1,054.6 -1,054.4 3,533.9 3,308.8 1,128.3 0.0 0.0   Pre-tax profit without non-rec. items   1,623 1,338 -1,248 4,314 4,133 1,683 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   13,832 12,812 23,674 15,525 22,096 14,456 0.0 0.0   Shareholders equity total   4,292 5,347 4,292 7,826 3,815 4,943 4,443 4,443   Interest-bearing liabilities   11,425 12,763 23,951 21,095 14,521 10,473 0.0 0.0   Balance sheet total (assets)   17,913 20,771 28,882 30,647 30,624 30,159 4,443 4,443   Net Debt   9,657 12,531 23,883 11,923 14,485 10,435 -2,753 -2,753     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   10,528 11,761 5,446 11,255 13,766 17,878 0.0 0.0   Gross profit growth   0.8% 11.7% -53.7% 106.6% 22.3% 29.9% -100.0% 0.0%   Employees   30 27 16 17 32 50 0 0   Employee growth %   11.1% -10.0% -40.7% 6.3% 88.2% 56.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   17,913 20,771 28,882 30,647 30,624 30,159 4,443 4,443   Balance sheet change%   130.5% 16.0% 39.0% 6.1% -0.1% -1.5% -85.3% 0.0%   Added value   2,464.1 2,544.2 455.6 5,877.9 6,130.6 4,289.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   9,260 1,102 9,407 -9,751 5,041 -9,741 -14,456 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   19.4% 15.5% -12.7% 40.7% 35.1% 14.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   16.1% 9.6% -2.4% 15.5% 15.9% 8.3% 0.0% 0.0%   ROI %   19.7% 10.9% -2.6% 16.0% 20.2% 14.5% 0.0% 0.0%   ROE %   30.2% 21.9% -21.9% 58.3% 56.8% 25.8% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   24.0% 25.7% 14.9% 25.5% 12.5% 16.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   391.9% 492.5% 5,241.6% 202.9% 239.1% 243.3% 0.0% 0.0%   Gearing %   266.2% 238.7% 558.0% 269.5% 380.6% 211.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.6% 4.3% 3.5% 1.3% 4.2% 6.8% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.3 0.3 0.2 0.7 0.3 0.3 0.0 0.0   Current Ratio   0.3 0.3 0.2 0.8 0.3 0.7 0.0 0.0   Cash and cash equivalent   1,768.3 232.3 68.4 9,171.7 35.9 38.6 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -9,570.6 -10,245.4 -12,853.1 -3,379.9 -13,733.6 -4,828.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   82 94 28 346 192 86 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   82 94 28 346 189 86 0 0   EBIT / employee   68 67 -43 270 151 50 0 0   Net earnings / employee   37 39 -66 208 103 23 0 0